scispace - formally typeset
S

Shmuel Banai

Researcher at Tel Aviv Sourasky Medical Center

Publications -  237
Citations -  6204

Shmuel Banai is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 34, co-authored 177 publications receiving 5629 citations. Previous affiliations of Shmuel Banai include National Institutes of Health & Hebrew University of Jerusalem.

Papers
More filters
Journal ArticleDOI

Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs.

TL;DR: It is concluded that intracoronary VEGF enhances the development of small coronary arteries supplying ischemic myocardium, resulting in marked augmentation of maximal collateral blood flow delivery and suggests a new therapeutic approach for the treatment of myocardial ischemia.
Journal ArticleDOI

Treatment of torsade de pointes with magnesium sulfate.

TL;DR: MgSO4 is a very effective and safe treatment for TdP, and its use is therefore recommended as the first line of therapy for TDP.
Journal ArticleDOI

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis.

TL;DR: VEGF production in the myocardium is significantly upregulated by hypoxia in vitro and by ischaemia in vivo, suggesting that VEGF is a likely mediator in the natural process of ischaemic induced myocardial neovascularisation.
Journal ArticleDOI

Basic fibroblast growth factor enhances myocardial collateral flow in a canine model

TL;DR: Exogenous administration of basic FGF enhances maximal collateral blood flow in dogs with myocardial ischemia secondary to single-vessel coronary occlusion, an effect that is likely mediated through the direct angiogenic effects of the peptide, although its acute vasodilatory effects may also play a role.
Journal ArticleDOI

Prognostic significance of ischemic episodes in patients with previous myocardial infarction.

TL;DR: Among patients with good or reduced left ventricular ejection fraction, those with transient ST depression on Holter had a significantly higher cardiac event rate compared with those without it and a similar event rate was found in patients with only silent, only symptomatic and with silent and symptomatic ischemic episodes.